Skip to content
TESCT — Trans European Stem Cell Therapy Society
Portrait of Lyle Armstrong, PhD

Newcastle University, United Kingdom

lyle.armstrong@tesct.org

Society members

Lyle Armstrong, PhD

Member — Cellular Reprogramming

  • BSc (Hons)
  • PhD Organic Chemistry

Lyle Armstrong holds a BSc (Hons) in Chemistry (1986) and a PhD in Organic Chemistry (1992) from Northumbria University, and is Professor of Cellular Reprogramming at Newcastle University and Chief Scientific Officer of Newcells Biotech Ltd.

He is holder of HFEA licence R0179-A to perform interspecies nuclear transfer, an EU site inspector for INSERM, Editor in Chief of the Stem Cells Portal and a member of the Rhode Island Stem Cell Review Scientific Panel. He has been primary research supervisor to 12 PhD students, two MPhils, seven postdoctoral research associates and three MRes/MSc students.

Academic record

  • 1992 — Co-founder and director of a contract research organisation, Newcastle upon Tyne
  • 2001 — Senior Research Associate, Department of Biological Sciences, Durham University
  • 2004 — Postdoctoral research fellow, Institute of Human Genetics, Newcastle University
  • 2004 — Lecturer in Stem Cell Biology, Newcastle University
  • 2008 — Senior Lecturer in Stem Cell Biology, Newcastle University
  • 2012 — Reader in Cellular Reprogramming, Newcastle University
  • 2015 — Professor of Cellular Reprogramming, Newcastle University
  • 2015 — Chief Scientific Officer, Newcells Biotech Ltd

  • 2018 — NC3R CRACK-IT challenge 29: ImmuLiver, £100,000 (SME Principal Investigator)
  • Horizon 2020 — Marie Skłodowska-Curie Actions, Initial Training Networks, £303,172 (Co-investigator)
  • NC3R CRACK-IT Challenge 24 — “3D iPSC derived laminated retinal model as a tool for toxicology studies”, £1,000,000 (SME Principal Investigator)
  • MRC project grant — “An iPSC based screen for candidate pain modulating compounds”, £617,000 (Principal Investigator)
  • MRC Confidence in Concept Funding, Newcastle — exosomes for age-related macular degeneration, £65,459 (Principal Investigator)
  • Horizon 2020 — Marie Skłodowska-Curie Actions, “An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment”, £250,000 (Principal Investigator)
  • 2016–2019 — NC3R CRACK-IT challenge 20: METABODERM, £800,000 (SME Principal Investigator)

  • Armstrong L, James AL, Monget D, Orenga S (1999) New chromogenic substrates for the detection of bacterial hydrolases. French Patent 9900781
  • Armstrong L, James AL, Monget D, Orenga S (1998) Chromogenic substrates for detecting enzyme activity, especially bacterial peptidase activity. French Patent FR9804332
  • Armstrong L, James AL, Orenga S (1998) Substrates and procedures for the detection of deaminase activity. French Patent 9802380
  • Armstrong L, James AL, Orenga S (1997) Detection of deaminase activity in microorganisms using a substituted alpha amino acid. French Patent 9714191
  • Armstrong L, James AL (1997) New enzymatically cleavable esculetin derivatives for the detection of microorganisms. British Patent GB9600024

Areas of work

  • Cellular reprogramming
  • Induced pluripotent stem cells
  • Toxicology models